ADXN

Addex Therapeutics Ltd

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$4.62

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.1 / %30

Non-compliant assets / Total market cap %3.2 / %30

Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.

Website

Analysis (Turkish): ADXN Hissesi Caiz mi, Helal mi? Addex Therapeutics Ltd Katılım Analizi